M&A Deal Summary |
|
---|---|
Date | 2025-02-14 |
Target | ENvue Medical |
Sector | Medical Products |
Buyer(s) | NanoVibronix |
Deal Type | Add-on Acquisition |
Advisor(s) | Haynes and Boone (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2003 |
Sector | Medical Products |
Employees | 10 |
Revenue | 2M USD (2023) |
NanoVibronix is a medical device company focused on developing medical devices utilizing its patented low-intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. NanoVibronix was founded in 2003 and is headquartered in Elmsford, New York.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Illinois) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2025) | 1 of 1 |